A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection

Blood testing is a clinical diagnostic tool to evaluate physiological conditions, the immune system response, or the presence of infection from whole blood samples. Although conventional blood testing can provide rich biological information, it usually requires complicated and tedious whole blood pr...

Full description

Bibliographic Details
Main Authors: Zhi-Xuan Lai, Chia-Chien Wu, Nien-Tsu Huang
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/12/12/1163
_version_ 1797461137381392384
author Zhi-Xuan Lai
Chia-Chien Wu
Nien-Tsu Huang
author_facet Zhi-Xuan Lai
Chia-Chien Wu
Nien-Tsu Huang
author_sort Zhi-Xuan Lai
collection DOAJ
description Blood testing is a clinical diagnostic tool to evaluate physiological conditions, the immune system response, or the presence of infection from whole blood samples. Although conventional blood testing can provide rich biological information, it usually requires complicated and tedious whole blood processing steps operated by benchtop instruments and well-experienced technicians, limiting its usage in point-of-care (POC) settings. To address the above problems, we propose a microfluidic platform for on-chip plasma extraction directly from whole blood and in situ biomarker detection. Herein, we chose C-reactive protein (CRP) as the target biomarker, which can be used to predict fatal cardiovascular disease (CVD) events such as heart attacks and strokes. To achieve a rapid, undiluted, and high-purity on-chip plasma extraction, we combined two whole blood processing methods: (1) anti-D immunoglobulin-assisted sedimentation, and (2) membrane filtration. To perform in situ CRP detection, we fabricated a three-dimensional (3D) microchannel with an embedded electrochemical (EC) sensor, which has a modular design to attach the blood collector and buffer reservoir with standard Luer connectors. As a proof of concept, we first confirmed that the dual plasma extraction design achieved the same purity level as the standard centrifugation method with smaller sample (100 µL of plasma extracted from 400 µL of whole blood) and time (7 min) requirements. Next, we validated the functionalization protocol of the EC sensor, followed by evaluating the detection of CRP spiked in plasma and whole blood. Our microfluidic platform performed on-chip plasma extraction directly from whole blood and in situ CRP detection at a 0.1–10 μg<i>/</i>mL concentration range, covering the CVD risk evaluation level of the high-sensitivity CRP (hs-CRP) test. Based on the above features, we believe that this platform constitutes a flexible way to integrate the processing of complex samples with accurate biomarker detection in a sample-to-answer POC platform, which can be applied in CVD risk monitoring under critical clinical situations.
first_indexed 2024-03-09T17:16:06Z
format Article
id doaj.art-4c25b1dff1ec414786d35221c0a9ed5a
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-09T17:16:06Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-4c25b1dff1ec414786d35221c0a9ed5a2023-11-24T13:37:40ZengMDPI AGBiosensors2079-63742022-12-011212116310.3390/bios12121163A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) DetectionZhi-Xuan Lai0Chia-Chien Wu1Nien-Tsu Huang2Graduation Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, TaiwanGraduation Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, TaiwanGraduation Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, TaiwanBlood testing is a clinical diagnostic tool to evaluate physiological conditions, the immune system response, or the presence of infection from whole blood samples. Although conventional blood testing can provide rich biological information, it usually requires complicated and tedious whole blood processing steps operated by benchtop instruments and well-experienced technicians, limiting its usage in point-of-care (POC) settings. To address the above problems, we propose a microfluidic platform for on-chip plasma extraction directly from whole blood and in situ biomarker detection. Herein, we chose C-reactive protein (CRP) as the target biomarker, which can be used to predict fatal cardiovascular disease (CVD) events such as heart attacks and strokes. To achieve a rapid, undiluted, and high-purity on-chip plasma extraction, we combined two whole blood processing methods: (1) anti-D immunoglobulin-assisted sedimentation, and (2) membrane filtration. To perform in situ CRP detection, we fabricated a three-dimensional (3D) microchannel with an embedded electrochemical (EC) sensor, which has a modular design to attach the blood collector and buffer reservoir with standard Luer connectors. As a proof of concept, we first confirmed that the dual plasma extraction design achieved the same purity level as the standard centrifugation method with smaller sample (100 µL of plasma extracted from 400 µL of whole blood) and time (7 min) requirements. Next, we validated the functionalization protocol of the EC sensor, followed by evaluating the detection of CRP spiked in plasma and whole blood. Our microfluidic platform performed on-chip plasma extraction directly from whole blood and in situ CRP detection at a 0.1–10 μg<i>/</i>mL concentration range, covering the CVD risk evaluation level of the high-sensitivity CRP (hs-CRP) test. Based on the above features, we believe that this platform constitutes a flexible way to integrate the processing of complex samples with accurate biomarker detection in a sample-to-answer POC platform, which can be applied in CVD risk monitoring under critical clinical situations.https://www.mdpi.com/2079-6374/12/12/1163microfluidicswhole blood processingelectrochemical (EC) detectionpoint-of-care (POC) settingscardiovascular disease (CVD)
spellingShingle Zhi-Xuan Lai
Chia-Chien Wu
Nien-Tsu Huang
A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
Biosensors
microfluidics
whole blood processing
electrochemical (EC) detection
point-of-care (POC) settings
cardiovascular disease (CVD)
title A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
title_full A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
title_fullStr A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
title_full_unstemmed A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
title_short A Microfluidic Platform with an Embedded Miniaturized Electrochemical Sensor for On-Chip Plasma Extraction Followed by In Situ High-Sensitivity C-Reactive Protein (hs-CRP) Detection
title_sort microfluidic platform with an embedded miniaturized electrochemical sensor for on chip plasma extraction followed by in situ high sensitivity c reactive protein hs crp detection
topic microfluidics
whole blood processing
electrochemical (EC) detection
point-of-care (POC) settings
cardiovascular disease (CVD)
url https://www.mdpi.com/2079-6374/12/12/1163
work_keys_str_mv AT zhixuanlai amicrofluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection
AT chiachienwu amicrofluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection
AT nientsuhuang amicrofluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection
AT zhixuanlai microfluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection
AT chiachienwu microfluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection
AT nientsuhuang microfluidicplatformwithanembeddedminiaturizedelectrochemicalsensorforonchipplasmaextractionfollowedbyinsituhighsensitivitycreactiveproteinhscrpdetection